Rare disease

Sickle Cell Disease

Clinical trials recruiting in Australia for Sickle Cell Disease, a rare disease, as the public registries list them.

Also called: Homozygous hemoglobin S; Homozygous sickle cell anemia SS; SCD; Sickle cell anaemia; Sickle cell anemia; Haemoglobin S disease; Hemoglobin S disease; HbS disease; Sickle cell disorders

Sources: ClinicalTrials.gov, MedlinePlus, Orphanet Checked: 11 October 2026 Not medical advice

At a glance

2 trials recruiting in Australia

221 trials recruiting overseas

1-5 / 10 000 (Point prevalence, United States, Validated) prevalence

All ages age of onset

11 October 2026 date last checked

Trials in Australia

This Australian count is likely to be on the low side. It counts the trials this site files under this condition; the registry’s own search is broader and also returns closely related conditions, some of which have their own page here. If you are searching widely, check the registry as well — every trial below links to its own record.

  • Recruiting Phase 3

    Phase 3 study for people with Sickle Cell Disease

    Where
    • Local Institution - 100, South Brisbane (QLD) — Completed
    • Royal Adelaide Hospital, Adelaide (SA) — Recruiting
    • Local Institution - 102, Clayton (VIC) — Completed
    • Royal Prince Alfred Hospital, Camperdown (NSW) — Recruiting
    Who can join Age 18 Years and over. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Celgene
    Timeline
    Started 12 August 2019 Today 16 October 2026 Estimated completion 12 May 2028

    NCT04064060 · Checked 11 October 2026

  • Recruiting Phase 3

    Phase 3 study for people with Sickle Cell Disease

    Where
    • Royal Prince Alfred Hospital - Department of Haematology, Camperdown (NSW) — Recruiting
    • Prince of Wales Hospital - Department of Haematology, Randwick (NSW) — Recruiting
    • Monash Medical Centre - Haematology Department, Clayton (VIC) — Recruiting
    • Fiona Stanley Hospital - Haemophilia and Haemostasis Centre, Murdoch (WA) — Recruiting
    Who can join Age 12 Years and over. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Novo Nordisk A/S
    Timeline
    Started 17 February 2025 Today 16 October 2026 Estimated completion 27 August 2027

    NCT06612268 · Checked 11 October 2026

Trials overseas

221 trials for this disease are open to new participants outside Australia, as ClinicalTrials.gov listed them on 11 October 2026. Voxsanity does not publish a page for any of them; the searches below reach them at the registry.

These overseas counts are likely too high. They come from the registry’s own search, which expands a condition name to related conditions, so some of the trials counted are for a different disease in the same family.

Trials not shown here

Some Australian trials are registered only on the Australian New Zealand Clinical Trials Registry and are not shown here. Search them at Australian Clinical Trials.

Key facts

Inheritance Autosomal recessive
Genes HBB
Prevalence 1-5 / 10 000 (Point prevalence, United States, Validated)
Age of onset All ages

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com).

About Sickle Cell Disease

The text below is reproduced exactly as its source published it. It has not been edited, shortened or rewritten.

What is sickle cell disease (SCD)? Sickle cell disease (SCD) is a group of inherited red blood cell disorders. If you have SCD, there is a problem with your hemoglobin. Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. With SCD, the hemoglobin forms into stiff rods within the red blood cells. This changes the shape of the red blood cells. The cells are supposed to be disc-shaped, but instead they are crescent, or sickle, shaped. The sickle-shaped cells are not flexible and cannot change shape easily. Many of them burst apart as they move through your blood vessels. The sickle cells usually only last 10 to 20 days, instead of the normal 90 to 120 days. Your body may have trouble making enough new cells to replace the ones that you lost. Because of this, you may not have enough red blood cells. This is a condition called anemia, and it can make you feel tired. The sickle-shaped cells can also stick to vessel walls, causing a blockage that slows or stops the flow of blood. When this happens, oxygen can't reach nearby tissues. The lack of oxygen can cause attacks of sudden, severe pain, called pain crises. These attacks can occur without warning. If you get one, you might need to go to the hospital for treatment. What causes sickle cell disease (SCD)? SCD is caused by a variant (change) in a gene that has instructions for your body to make one part of the hemoglobin. This changed gene is sometimes called a sickle cell gene. People with SCD are born with two sickle cell genes, one from each parent. If you are born with one sickle cell gene, it's called sickle cell trait. People with sickle cell trait are generally healthy, but they can pass the defective gene on to their children. Who is more likely to have sickle cell disease (SCD)? In the United States, most of the people with SCD are African Americans: - About 1 in 13 Black or African American babies are born with sickle cell trait - About 1 in every 365 Black or African American babies are born with sickle cell disease SCD also affects some people who come from Hispanic, southern European, Middle Eastern, or Asian Indian backgrounds. What are the symptoms of sickle cell disease (SCD)? People with SCD start to have signs of the disease during the first year of life, usually around 5 or 6 months of age. Early symptoms of SCD may include: - Painful swelling of the hands and feet - Fatigue or fussiness from anemia - A yellowish color of the skin (jaundice) or the whites of the eyes (icterus) The effects of SCD vary from person to person and can change over time. Most of the signs and symptoms of SCD are related to complications of the disease. They may include severe pain, anemia, organ damage, and infections. How is sickle cell disease (SCD) diagnosed? A blood test can show if you have SCD or sickle cell trait. Genetic tests can tell if you have one or two copies of the sickle cell gene. Genetic tests can help confirm an SCD diagnosis if the results from blood tests are not clear. All states now test newborns for SCD (as well as many other treatable conditions) as part of their screening programs. These programs help find the conditions early, so treatment can be started right away. Health care providers can also diagnose SCD before a baby is born. That test uses a sample of amniotic fluid (the liquid in the sac surrounding the baby) or tissue taken from the placenta (the organ that brings oxygen and nutrients to the baby). People who are thinking about having children can have the test to find out how likely it is that their children will have SCD. What are the treatments for sickle cell disease (SCD)? There are many ways to manage sickle cell disease. Your medical team will probably include a hematologist, a doctor who specializes in blood diseases. You will work with your medical team to set up a treatment plan. Possible treatment options may include: - Treatments that can help relieve symptoms and lessen complications, including: - Hydroxyurea, a medicine to reduce sickling of red blood cells. This can help prevent serious symptoms of sickle cell disease. This medicine can be used in adults and in children as young as 9 months old. But this medicine is not safe during pregnancy. - Voxelotor, another medicine to prevent the sickling of red blood cells. It can be used in adults and children ages 4 years and older. - Pain relievers for acute or chronic pain. - Antibiotics to try to prevent infections in younger children. - Blood transfusions for severe anemia. If you have had some serious complications, such as a stroke, you may have transfusions to prevent more complications. - Other treatments for specific complications, such as medicines to lower blood pressure and vitamins to treat a vitamin deficiency. - Bone marrow or stem cell transplantation, which can cure SCD. Because these transplants are risky and can have serious side effects, they are usually only used in children with severe SCD. For the transplant to work, the bone marrow must be a close match. Usually, the best donor is a brother or sister. - Gene therapies to treat SCD in people who are 12 years and older and have had repeated sickle cell crises. These new therapies involve taking some of your blood stem cells and either adding new DNA to them or changing their existing DNA. Then these cells are given back to you, and they can make a type of hemoglobin that is healthy. This can reduce the complications of SCD, including the SCD crises. Complementary and alternative medicine (CAM) seems to help some people deal with pain caused by SCD. These types of CAM may lower your pain, especially if it is not well managed with medicines:: - Cognitive behavioral therapy (a type of counseling) - Acupuncture - Exercise or movement programs, such as yoga - Massage - Meditation and mindfulness practices - Virtual reality, a computer-generated 3D environment you can see with special goggles It's also important to take steps to keep yourself as healthy as possible: - Get regular medical care - Get your routine vaccinations - Live a healthy lifestyle - Avoid situations that may set off a pain crisis NIH: National Heart, Lung, and Blood Institute

US source; availability in Australia may differ.

Source: MedlinePlus Health Topics (medlineplus.gov), public domain (U.S. National Library of Medicine). Read the full source.

Sources and dates

  • ClinicalTrials.gov – trial records, statuses and site lists
  • MedlinePlus – the About text above, reproduced exactly
  • Orphanet / Orphadata – prevalence, age of onset, inheritance, genes and alternative names, used under CC BY 4.0
  • ClinicalTrials.gov processing date: 17 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Orphanet citation

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com). Accessed 20 September 2026.

ORPHA:232

Tell us which conditions matter to you

We use requests to help decide what to add next. Telling us about a condition is not a promise that we will add it, and we cannot say when any condition might appear.